Clinical Trial Update: Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing macular changes after intracameral moxifloxacin for endophthalmitis prevention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endophthalmitis
• Macular Edema

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Universidade Federal de Pernambuco | Conditions: Endophthalmitis, Macula Edema | Phase 4 | Status: COMPLETED